Novel p53 target gene FUCA1 encodes a fucosidase and regulates growth and survival of cancer cells

Cancer Science

Volumn 107, Issue 6, 2016, Pages 734-745

  Ezawa, Issei ^a,b   Sawai, Yuichiro ^a,c   Kawase, Tatsuya ^a,c   Okabe, Atsushi ^d,e   Tsutsumi, Shuichi ^d   Ichikawa, Hitoshi ^a   Kobayashi, Yuka ^f   Tashiro, Fumio ^c   Namiki, Hideo ^b   Kondo, Tadashi ^a   Semba, Kentaro ^b   Aburatani, Hiroyuki ^d   Taya, Yoichi ^a   Nakagama, Hitoshi ^a   Ohki, Rieko ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b WASEDA UNIVERSITY   (Japan)

^c TOKYO UNIVERSITY OF SCIENCE   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e CHIBA UNIVERSITY   (Japan)

^f J Oil Mills Inc   (Japan)

Author keywords

EGFR; FUCA1; fucosidase; fucosylation; p53

Indexed keywords

ALPHA LEVO FUCOSIDASE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P53;

ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CARCINOGENESIS; CELL DEATH; CELL SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME ACTIVITY; FUCA1 GENE; FUCOSYLATION; GENE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LARGE INTESTINE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN DEFUCOSYLATION; PROTEIN MODIFICATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 84979083732     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12933     Document Type: Article

References (39)

1. Aylon Y, Oren M. Living with p53, dying of p53. Cell 2007; 130: 597–600.
2. Harris SL, Levine AJ. The p53 pathway: positive and negative feedback loops. Oncogene 2005; 24: 2899–908.
3. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997; 88: 323–31.
4. Vousden KH, Prives C. Blinded by the light: the growing complexity of p53. Cell 2009; 137: 413–31.
5. Oda E, Ohki R, Murasawa H et al. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 2000; 288: 1053–8.
6. Ohki R, Kawase T, Ohta T, Ichikawa H, Taya Y. Dissecting functional roles of p53 N-terminal transactivation domains by microarray expression analysis. Cancer Sci 2007; 98: 189–200.
7. Ohki R, Nemoto J, Murasawa H et al. Reprimo, a new candidate mediator of the p53-mediated cell cycle arrest at the G2 phase. J Biol Chem 2000; 275: 22627–30.
8. Ohki R, Saito K, Chen Y et al. PHLDA3 is a novel tumor suppressor of pancreatic neuroendocrine tumors. Proc Natl Acad Sci USA 2014; 111: E2404–13.
9. Kawase T, Ichikawa H, Ohta T et al. p53 target gene AEN is a nuclear exonuclease required for p53-dependent apoptosis. Oncogene 2008; 27: 3797–810.
10. Kawase T, Ohki R, Shibata T et al. PH domain-only protein PHLDA3 is a p53-regulated repressor of Akt. Cell 2009; 136: 535–50.
11. Darby JK, Johnsen J, Nakashima P et al. Pvu II RFLP at the human chromosome 1 alpha-l-fucosidase gene locus (FUCA1). Nucleic Acids Res 1986; 14: 9543.
12. Willems PJ, Darby JK, DiCioccio RA et al. Identification of a mutation in the structural alpha-l-fucosidase gene in fucosidosis. Am J Hum Genet 1988; 43: 756–63.
13. Willems PJ, Seo HC, Coucke P, Tonlorenzi R, O'Brien JS. Spectrum of mutations in fucosidosis. Eur J Hum Genet 1999; 7: 60–7.
14. Miyoshi E, Moriwaki K, Nakagawa T. Biological function of fucosylation in cancer biology. J Biochem 2008; 143: 725–9.
15. Takeda Y, Shinzaki S, Okudo K, Moriwaki K, Murata K, Miyoshi E. Fucosylated haptoglobin is a novel type of cancer biomarker linked to the prognosis after an operation in colorectal cancer. Cancer 2012; 118: 3036–43.
16. Lin H, Wang D, Wu T et al. Blocking core fucosylation of TGF-beta1 receptors downregulates their functions and attenuates the epithelial-mesenchymal transition of renal tubular cells. Am J Physiol Renal Physiol 2011; 300: F1017–25.
17. Wang X, Gu J, Ihara H, Miyoshi E, Honke K, Taniguchi N. Core fucosylation regulates epidermal growth factor receptor-mediated intracellular signaling. J Biol Chem 2006; 281: 2572–7.
18. Zhao Y, Itoh S, Wang X et al. Deletion of core fucosylation on alpha3beta1 integrin down-regulates its functions. J Biol Chem 2006; 281: 38343–50.
19. Hu P, Shi B, Geng F, Zhang C, Wu W, Wu XZ. E-cadherin core fucosylation regulates nuclear beta-catenin accumulation in lung cancer cells. Glycoconj J 2008; 25: 843–50.
20. Osumi D, Takahashi M, Miyoshi E et al. Core fucosylation of E-cadherin enhances cell-cell adhesion in human colon carcinoma WiDr cells. Cancer Sci 2009; 100: 888–95.
21. Kyselova Z, Mechref Y, Kang P et al. Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles. Clin Chem 2008; 54: 1166–75.
22. Muinelo-Romay L, Vazquez-Martin C, Villar-Portela S, Cuevas E, Gil-Martin E, Fernandez-Briera A. Expression and enzyme activity of alpha(1,6)fucosyltransferase in human colorectal cancer. Int J Cancer 2008; 123: 641–6.
23. Kaneshiro K, Tsutsumi S, Tsuji S, Shirahige K, Aburatani H. An integrated map of p53-binding sites and histone modification in the human ENCODE regions. Genomics 2007; 89: 178–88.
24. Abascal I, Skalaban SR, Grimm KM et al. Alteration of the isoform composition of plasma-membrane-associated rat sperm alpha-l-fucosidase during late epididymal maturation: comparative characterization of the acidic and neutral isoforms. Biochem J 1998; 333(Pt 1): 201–7.
25. Winchester B, Barker C, Baines S et al. Inhibition of alpha-l-fucosidase by derivatives of deoxyfuconojirimycin and deoxymannojirimycin. Biochem J 1990; 265: 277–82.
26. Asano Y, Kawase T, Okabe A et al. IER5 generates a novel hypo-phosphorylated active form of HSF1 and contributes to tumorigenesis. Sci Rep 2016; 6: 19174.
27. Wang B, Xiao Z, Ren EC. Redefining the p53 response element. Proc Natl Acad Sci USA 2009; 106: 14373–8.
28. Yang A, Zhu Z, Kapranov P et al. Relationships between p63 binding, DNA sequence, transcription activity, and biological function in human cells. Mol Cell 2006; 24: 593–602.
29. Yang A, Zhu Z, Kettenbach A et al. Genome-wide mapping indicates that p73 and p63 co-occupy target sites and have similar dna-binding profiles in vivo. PLoS One 2010; 5: e11572.
30. Sleat DE, Jadot M, Lobel P. Lysosomal proteomics and disease. Proteomics Clin Appl 2007; 1: 1134–46.
31. Becker DJ, Lowe JB. Fucose: biosynthesis and biological function in mammals. Glycobiology 2003; 13: 41R–53R.
32. Kobayashi Y, Tateno H, Dohra H et al. A novel core fucose-specific lectin from the mushroom Pholiota squarrosa. J Biol Chem 2012; 287: 33973–82.
33. Kobayashi Y, Kawagishi H. Fungal lectins: a growing family. Methods Mol Biol 2014; 1200: 15–38.
34. Ragnarsson G, Eiriksdottir G, Johannsdottir JT et al. Loss of heterozygosity at chromosome 1p in different solid human tumours: association with survival. Br J Cancer 1999; 79: 1468–74.
35. Sulzenbacher G, Bignon C, Nishimura T et al. Crystal structure of Thermotoga maritima alpha-l-fucosidase. Insights into the catalytic mechanism and the molecular basis for fucosidosis. J Biol Chem 2004; 279: 13119–28.
36. Mizuno H, Kitada K, Nakai K, Sarai A. PrognoScan: a new database for meta-analysis of the prognostic value of genes. BMC Med Genomics 2009; 2: 18.
37. Otero-Estevez O, Martinez-Fernandez M, Vazquez-Iglesias L, Paez de la Cadena M, Rodriguez-Berrocal FJ, Martinez-Zorzano VS. Decreased expression of alpha-l-fucosidase gene FUCA1 in human colorectal tumors. Int J Mol Sci 2013; 14: 16986–98.
38. Listinsky JJ, Siegal GP, Listinsky CM. The emerging importance of alpha-l-fucose in human breast cancer: a review. Am J Transl Res 2011; 3: 292–322.
39. Ciriello G, Gatza ML, Beck AH et al. Comprehensive molecular portraits of invasive lobular breast cancer. Cell 2015; 163: 506–19.